Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis

While ground-glass opacity, consolidation, and fibrosis in the lungs are some of the hallmarks of acute SAR-CoV-2 infection, it remains unclear whether these pulmonary radiological findings would resolve after acute symptoms have subsided. We conducted a systematic review and meta-analysis to evalua...

Full description

Bibliographic Details
Main Authors: Mustufa Babar, Hasan Jamil, Neil Mehta, Ahmed Moutwakil, Tim Q. Duong
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/14/6/621
_version_ 1797241473921449984
author Mustufa Babar
Hasan Jamil
Neil Mehta
Ahmed Moutwakil
Tim Q. Duong
author_facet Mustufa Babar
Hasan Jamil
Neil Mehta
Ahmed Moutwakil
Tim Q. Duong
author_sort Mustufa Babar
collection DOAJ
description While ground-glass opacity, consolidation, and fibrosis in the lungs are some of the hallmarks of acute SAR-CoV-2 infection, it remains unclear whether these pulmonary radiological findings would resolve after acute symptoms have subsided. We conducted a systematic review and meta-analysis to evaluate chest computed tomography (CT) abnormalities stratified by COVID-19 disease severity and multiple timepoints post-infection. PubMed/MEDLINE was searched for relevant articles until 23 May 2023. Studies with COVID-19-recovered patients and follow-up chest CT at least 12 months post-infection were included. CT findings were evaluated at short-term (1–6 months) and long-term (12–24 months) follow-ups and by disease severity (severe and non-severe). A generalized linear mixed-effects model with random effects was used to estimate event rates for CT findings. A total of 2517 studies were identified, of which 43 met the inclusion (N = 8858 patients). Fibrotic-like changes had the highest event rate at short-term (0.44 [0.3–0.59]) and long-term (0.38 [0.23–0.56]) follow-ups. A meta-regression showed that over time the event rates decreased for any abnormality (β = −0.137, <i>p</i> = 0.002), ground-glass opacities (β = −0.169, <i>p</i> < 0.001), increased for honeycombing (β = 0.075, <i>p</i> = 0.03), and did not change for fibrotic-like changes, bronchiectasis, reticulation, and interlobular septal thickening (<i>p</i> > 0.05 for all). The severe subgroup had significantly higher rates of any abnormalities (<i>p</i> < 0.001), bronchiectasis (<i>p</i> = 0.02), fibrotic-like changes (<i>p</i> = 0.03), and reticulation (<i>p</i> < 0.001) at long-term follow-ups when compared to the non-severe subgroup. In conclusion, significant CT abnormalities remained up to 2 years post-COVID-19, especially in patients with severe disease. Long-lasting pulmonary abnormalities post-SARS-CoV-2 infection signal a future public health concern, necessitating extended monitoring, rehabilitation, survivor support, vaccination, and ongoing research for targeted therapies.
first_indexed 2024-04-24T18:23:54Z
format Article
id doaj.art-c75d97d57e044d748a11394808c8eecf
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-04-24T18:23:54Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-c75d97d57e044d748a11394808c8eecf2024-03-27T13:33:21ZengMDPI AGDiagnostics2075-44182024-03-0114662110.3390/diagnostics14060621Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-AnalysisMustufa Babar0Hasan Jamil1Neil Mehta2Ahmed Moutwakil3Tim Q. Duong4Department of Radiology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USADivision of Surveillance and Policy Evaluation, National Cancer Center Institute for Cancer Control, Tokyo 104-0045, JapanDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USADepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USADepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USAWhile ground-glass opacity, consolidation, and fibrosis in the lungs are some of the hallmarks of acute SAR-CoV-2 infection, it remains unclear whether these pulmonary radiological findings would resolve after acute symptoms have subsided. We conducted a systematic review and meta-analysis to evaluate chest computed tomography (CT) abnormalities stratified by COVID-19 disease severity and multiple timepoints post-infection. PubMed/MEDLINE was searched for relevant articles until 23 May 2023. Studies with COVID-19-recovered patients and follow-up chest CT at least 12 months post-infection were included. CT findings were evaluated at short-term (1–6 months) and long-term (12–24 months) follow-ups and by disease severity (severe and non-severe). A generalized linear mixed-effects model with random effects was used to estimate event rates for CT findings. A total of 2517 studies were identified, of which 43 met the inclusion (N = 8858 patients). Fibrotic-like changes had the highest event rate at short-term (0.44 [0.3–0.59]) and long-term (0.38 [0.23–0.56]) follow-ups. A meta-regression showed that over time the event rates decreased for any abnormality (β = −0.137, <i>p</i> = 0.002), ground-glass opacities (β = −0.169, <i>p</i> < 0.001), increased for honeycombing (β = 0.075, <i>p</i> = 0.03), and did not change for fibrotic-like changes, bronchiectasis, reticulation, and interlobular septal thickening (<i>p</i> > 0.05 for all). The severe subgroup had significantly higher rates of any abnormalities (<i>p</i> < 0.001), bronchiectasis (<i>p</i> = 0.02), fibrotic-like changes (<i>p</i> = 0.03), and reticulation (<i>p</i> < 0.001) at long-term follow-ups when compared to the non-severe subgroup. In conclusion, significant CT abnormalities remained up to 2 years post-COVID-19, especially in patients with severe disease. Long-lasting pulmonary abnormalities post-SARS-CoV-2 infection signal a future public health concern, necessitating extended monitoring, rehabilitation, survivor support, vaccination, and ongoing research for targeted therapies.https://www.mdpi.com/2075-4418/14/6/621SARS-CoV-2long COVIDpost-acute COVID-19 syndrome (PASC)computed tomographypulmonary sequela
spellingShingle Mustufa Babar
Hasan Jamil
Neil Mehta
Ahmed Moutwakil
Tim Q. Duong
Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis
Diagnostics
SARS-CoV-2
long COVID
post-acute COVID-19 syndrome (PASC)
computed tomography
pulmonary sequela
title Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis
title_full Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis
title_fullStr Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis
title_full_unstemmed Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis
title_short Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis
title_sort short and long term chest ct findings after recovery from covid 19 a systematic review and meta analysis
topic SARS-CoV-2
long COVID
post-acute COVID-19 syndrome (PASC)
computed tomography
pulmonary sequela
url https://www.mdpi.com/2075-4418/14/6/621
work_keys_str_mv AT mustufababar shortandlongtermchestctfindingsafterrecoveryfromcovid19asystematicreviewandmetaanalysis
AT hasanjamil shortandlongtermchestctfindingsafterrecoveryfromcovid19asystematicreviewandmetaanalysis
AT neilmehta shortandlongtermchestctfindingsafterrecoveryfromcovid19asystematicreviewandmetaanalysis
AT ahmedmoutwakil shortandlongtermchestctfindingsafterrecoveryfromcovid19asystematicreviewandmetaanalysis
AT timqduong shortandlongtermchestctfindingsafterrecoveryfromcovid19asystematicreviewandmetaanalysis